LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Drug Safety Update › 17 Dec 2025
Drug Safety Update

Rybelsus ® (semaglutide tablets)

Published on 17 Dec 2025 · source: MHRA — Medicines and Healthcare products Regulatory Agency
There is a risk of patient harm arising through medication error during a transition period where the original and new formulation of Rybelsus ® tablets, which have different stated mg doses but are b…
Drug Safety Update on GOV.UK ↗ All events: Rybelsus ® (semaglutide tablets)

What this means

Drug Safety Update is the MHRA bulletin for healthcare professionals: new safety information, restrictions of use and recommendations for monitoring.

Summary

There is a risk of patient harm arising through medication error during a transition period where the original and new formulation of Rybelsus ® tablets, which have different stated mg doses but are bioequivalent, will both be available on the market.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.